Bill would classify animal sedative xylazine as controlled substance
Passed one chamberH.R. 1266Latest action
Sponsor: Jimmy Panetta · Representative · CA
AIDecoded by AI · checked against the recordRead the official text
Official title: Combating Illicit Xylazine Act
119th Congress
Topics: Crime & justice
Introduced:
Read the official bill on Congress.govIn plain words
The plain-language version comes first. The official text is always the reference.
HR 1266 would make xylazine a Schedule III controlled substance while preserving legal veterinary access.
30-second read · 4 questions answered below
What does this do?
The bill classifies xylazine, an animal sedative increasingly found mixed into illegal drugs like fentanyl, as a Schedule III controlled substance. It preserves legal access for veterinary use and gives manufacturers and practitioners transition periods of 60 days to a year before new labeling, recordkeeping, and registration rules take effect.
Who does it affect?
Veterinarians, pharmacies, animal owners, animal-control and wildlife programs, drug manufacturers, and law enforcement are directly affected; communities facing the opioid crisis are indirectly affected.
Why does it matter?
Xylazine contamination makes overdoses harder to reverse with standard treatments like naloxone, prompting tighter federal controls alongside continued legal veterinary use.
AI-drafted summary. Check it against the official text before you act on it.
Read the official bill on Congress.govMake the call
Where does it stand?
- IntroducedFeb 12, 2025
- House committee
- House vote
- SenateYou are here · Sep 16, 2026
- The president's desk
Right now: it passed the House, and the official record shows nothing new since. If the Senate changes it, it goes back to the House before reaching the president.
Latest action: — Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623.